Bradley Wagner

Research Scientist

Bradley Wagner

Research Scientist


Bradley Wagner has a Ph.D. in Applied Mathematics from McMaster University (Hamilton, Ontario, Canada), where he also has a Master of Science in Mathematics. Additionally, he has a Bachelor of Science in Mathematics as well as Chemistry from the University of British Columbia. Prior to joining IDM, Bradley was a postdoctoral fellow at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Bradley’s postdoctoral research focused on the mathematical modeling of HIV drug resistance, while his Ph.D. research concentrated on the mathematical modeling of childhood infectious disease dynamics including the design of optimal vaccination strategies. His research within IDM is an extension of that previous work, with a focus on developing and implementing mathematical models of HIV and tuberculosis (TB) transmission and the goal of designing effective treatment and prevention programs.

Biography

Bradley Wagner has a Ph.D. in Applied Mathematics from McMaster University (Hamilton, Ontario, Canada), where he also has a Master of Science in Mathematics. Additionally, he has a Bachelor of Science in Mathematics as well as Chemistry from the University of British Columbia. Prior to joining IDM, Bradley was a postdoctoral fellow at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Bradley’s postdoctoral research focused on the mathematical modeling of HIV drug resistance, while his Ph.D. research concentrated on the mathematical modeling of childhood infectious disease dynamics including the design of optimal vaccination strategies. His research within IDM is an extension of that previous work, with a focus on developing and implementing mathematical models of HIV and tuberculosis (TB) transmission and the goal of designing effective treatment and prevention programs.

Publications

Friday, July 6, 2018
Here we describe the process and advantages of a multi-disease framework approach developed with formal software support.
Read online
Thursday, April 12, 2018
​Gold mine workers are estimated to contribute a disproportionately large number of Mtb infections in South Africa on a per-capita basis; however, mine workers contribute only a small fraction of over
Read online
Tuesday, November 1, 2016

The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by 50% and mortality by 75% by 2025.

Read online
Thursday, October 6, 2016

​​The post-2015 End TB Strategy proposes targets of 50% reduction in TB incidence and 75% reduction in mortality from TB by 2025.

Read online
Thursday, May 21, 2015

In the last 20 years, China ramped up a DOTS (directly observed treatment, short-course)-based tuberculosis (TB) control program with 80% population coverage, achieving the 20

Read online
Tuesday, April 21, 2015

In the last 20 years, China ramped up a DOTS (directly observed treatment, short-course)-based tuberculosis (TB) control program with 80% population coverage, achieving the 2015 Millennium Developm

Read online
Monday, December 1, 2014
Using an individual-based mathematical model, we quantified the impact of EAG campaigns in terms of probability of elimination, reduction in polio transmission and age stratified immunity levels.
Read online
Thursday, July 24, 2014

Evidence that antiretroviral therapy reduces HIV infectiousness, suggests that increasing the number of HIV-positive adults who are on treatment could have the potential to change the course of the

Read online